CA
PLSE icon

Cetera Advisors’s Pulse Biosciences PLSE Stock Holding History

Cetera Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$109K Buy
+12,548
New +$115K ﹤0.01% 2298

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cetera Advisors's PLSE Position: Q1 2024 in Review

Cetera Advisors opened a new position in Pulse Biosciences (PLSE) in Q1 2024: 12,548 shares worth $109K. The stake represents ﹤0.01% of the portfolio and ranks #2298 among its holdings.

62 funds tracked by Wall St. Rank hold PLSE as of Q1 2024.

  • Cetera Advisors held 12,548 shares of Pulse Biosciences worth $109K as of Q1 2024.
  • Pulse Biosciences was a new Cetera Advisors position in Q1 2024.
  • Pulse Biosciences made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2298 holding.
  • 62 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.